SLC6A4 and depressive symptom measurement: This aligns with findings from genetic studies of depression and anxiety, which have suggested that BPAD shares common genetic risk factors with these disorders, particularly those related to the serotonin transporter gene (SERT) and brain-derived neurotrophic factor (BDNF) [13,14].